Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 87 52894 860132 331145 062--
Entreprise Value (EV)1 102 011109 142144 340158 639156 757155 285
P/E ratio 29,2x44,0x97,9x50,7x36,4x25,5x
Yield 4,05%3,74%2,78%2,54%2,57%2,64%
Capitalization / Revenue 3,90x4,29x5,43x5,43x4,83x4,27x
EV / Revenue 4,54x4,94x5,92x5,94x5,21x4,57x
EV / EBITDA 15,2x15,3x21,6x19,4x15,5x12,2x
Price to Book 5,85x7,61x10,00x10,6x9,79x7,97x
Nbr of stocks (in thousands) 1 265 9821 266 8121 311 9131 312 279--
Reference price (USD) 69,174,9101111111111
Last update 02/02/201802/14/201902/14/202008/05/202008/05/202008/05/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 22 46522 09024 38426 71230 05933 977
EBITDA1 6 7137 1406 6868 16510 14512 684
Operating profit (EBIT)1 6 8555 6726 4367 4079 05311 033
Operating Margin 30,5%25,7%26,4%27,7%30,1%32,5%
Pre-Tax Profit (EBT)1 2 2271 9931 5483 7755 9708 871
Net income1 3 0012 1551 3353 0674 3256 239
Net margin 13,4%9,76%5,47%11,5%14,4%18,4%
EPS2 2,371,701,032,183,034,34
Dividend per Share2 2,802,802,802,812,852,92
Last update 02/02/201802/14/201902/14/202008/05/202008/05/202008/05/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 14 48314 28212 00913 57811 69510 223
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,16x2,00x1,80x1,66x1,15x0,81x
Free Cash Flow1 2 2521 5751 9903 1456 0677 832
ROE (Net Profit / Equities) 36,4%32,0%35,6%38,1%45,1%50,8%
Shareholders' equity1 8 2506 7423 7528 0429 58912 272
ROA (Net Profit / Asset) 4,77%7,07%2,19%5,30%8,99%-
Assets1 62 94030 48061 01557 86348 093-
Book Value Per Share2 11,89,8410,110,411,313,9
Cash Flow per Share2 2,822,072,282,125,456,65
Capex1 1 3261 0439791 0901 2251 299
Capex / Sales 5,90%4,72%4,01%4,08%4,08%3,82%
Last update 02/02/201802/14/201902/14/202008/06/202008/06/202008/04/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (GBP)
111 150 030 029
Capitalization (USD)
145 125 318 295
Net sales (USD)
24 384 000 000
Number of employees
70 600
Sales / Employee (USD)
345 382
Free-Float
95,7%
Free-Float capitalization (GBP)
106 408 808 452
Free-Float capitalization (USD)
138 934 845 019
Avg. Exchange 20 sessions (USD)
16 800 753 255
Average Daily Capital Traded
15,1%
EPS & Dividend